WATER III: Aquablation vs. Transurethral Laser Enucleation of Large Prostates (80 - 180mL) in Benign Prostatic Hyperplasia — WATER III  

BPH With Urinary Obstruction With Other Lower Urinary Tract Symptoms Clinical Trial

Official title: WATER III: Aquablation vs. Transurethral Laser Enucleation of Large Prostates (80-180ml) in Benign Prostatic Hyperplasia

Status Recruiting

Clinical Trial Summary

Comparative analysis of efficacy and safety of Aquablation (AQUABEAM Robotic System®, PROCEPT BioRobotics, Redwood City, CA, USA) and transurethral laser enucleation as surgical therapy for benign prostatic hyperplasia with large prostates (80-180ml).

Clinical Trial Description

Prospective randomized and non-randomized cohort, two-arm multicenter trial two arm multicenter trial to evaluate the efficacy and safety of Aquablation (AQUABEAM Robotic System®, PROCEPT BioRobotics, Redwood City, CA, USA) compared to transurethral laser enucleation - the current reference standard of minimal invasive therapy for benign prostatic hyperplasia in large prostates (80-180ml). ;

Related Conditions & MeSH terms

• BPH With Urinary Obstruction With Other Lower Urinary Tract Symptoms
• Hyperplasia
• Lower Urinary Tract Symptoms
• Prostatic Hyperplasia

• NCT number: NCT04801381
• Study type: Interventional
• Source: University of Bonn
• Contact: Johannes Stein, Dr. med.
• Phone: 0049228/28714184
• Email: johannes.stein@ukbonn.de
• Status: Recruiting
• Phase: N/A
• Start date: December 16, 2020
• Completion date: December 2028